"""
LUMIMAP V2: Complete System Workflow
=====================================

This document explains how all the components work together
"""

WORKFLOW_DIAGRAM = """

┌──────────────────────────────────────────────────────────────────────────┐
│                         LUMIMAP V2 SYSTEM ARCHITECTURE                    │
└──────────────────────────────────────────────────────────────────────────┘


                              ┌─────────────────┐
                              │  BBBC021 Data   │
                              │  ─────────────  │
                              │  • DAPI images  │
                              │  • Tubulin imgs │
                              │  • Actin images │
                              │  • MOA labels   │
                              │  • Compounds    │
                              │  • Concentr.    │
                              └────────┬────────┘
                                       │
                                       ▼
┌──────────────────────────────────────────────────────────────────────────┐
│                           TRAINING PHASE                                  │
│  (resistance_type_classifier_train.py)                                   │
└──────────────────────────────────────────────────────────────────────────┘
                                       │
                    ┌──────────────────┼──────────────────┐
                    │                  │                  │
                    ▼                  ▼                  ▼
          ┌────────────────┐  ┌────────────────┐  ┌────────────────┐
          │  DAPI Encoder  │  │ Tubulin Encoder│  │  Actin Encoder │
          │   (ResNet50)   │  │   (ResNet50)   │  │   (ResNet50)   │
          └────────┬───────┘  └────────┬───────┘  └────────┬───────┘
                   │                   │                   │
                   └───────────────────┼───────────────────┘
                                       │
                                       ▼
                            ┌──────────────────┐
                            │ Channel Attention│
                            │  (Learn weights  │
                            │  for each channel│
                            │  per drug MOA)   │
                            └────────┬─────────┘
                                     │
                    ┌────────────────┼────────────────┐
                    │                                 │
                    ▼                                 ▼
          ┌──────────────────┐              ┌──────────────────┐
          │  Concentration   │              │  Feature Fusion  │
          │    Encoding      │─────────────▶│                  │
          │  (Drug dose)     │              │                  │
          └──────────────────┘              └────────┬─────────┘
                                                      │
                                                      ▼
                                          ┌──────────────────────┐
                                          │   8-Class Classifier │
                                          │   ─────────────────  │
                                          │   1. Sensitive       │
                                          │   2. Endocrine       │
                                          │   3. Drug Efflux     │
                                          │   4. Apoptosis Res.  │
                                          │   5. Metabolic       │
                                          │   6. ncRNA           │
                                          │   7. EMT-Like        │
                                          │   8. Target Therapy  │
                                          └──────────┬───────────┘
                                                     │
                                                     ▼
                                          ┌──────────────────────┐
                                          │   Trained Model      │
                                          │  best_resistance_    │
                                          │     model.pth        │
                                          └──────────────────────┘


┌──────────────────────────────────────────────────────────────────────────┐
│                          INFERENCE PHASE                                  │
│  (resistance_inference.py)                                               │
└──────────────────────────────────────────────────────────────────────────┘

         ┌────────────────────────────────────────────────┐
         │          NEW PATIENT SAMPLE                     │
         │          ─────────────────                      │
         │          • DAPI image                           │
         │          • Tubulin image                        │
         │          • Actin image                          │
         │          • Drug name (e.g., taxol)              │
         │          • Concentration (e.g., 1.0 µM)         │
         └───────────────────┬────────────────────────────┘
                             │
                             ▼
                ┌────────────────────────────┐
                │    Trained Model           │
                │    (Forward Pass)          │
                └──────────┬─────────────────┘
                           │
           ┌───────────────┼───────────────┐
           │               │               │
           ▼               ▼               ▼
    ┌───────────┐   ┌───────────┐   ┌───────────────┐
    │Resistance │   │  GradCAM  │   │   Therapy     │
    │   Type    │   │ Per Channel│   │Recommendation │
    │           │   │           │   │    Engine     │
    │ "Drug     │   │ • DAPI    │   │               │
    │  Efflux"  │   │ • Tubulin │   │ therapy_      │
    │           │   │ • Actin   │   │ recommenda... │
    │ 87.3%     │   │ • Combined│   │   database.py │
    └─────┬─────┘   └─────┬─────┘   └───────┬───────┘
          │               │                 │
          └───────────────┼─────────────────┘
                          │
                          ▼
              ┌───────────────────────┐
              │   FINAL OUTPUT        │
              │   ────────────        │
              │                       │
              │  1. Visualization     │
              │     (PNG with:)       │
              │     • GradCAM maps    │
              │     • Probabilities   │
              │     • Recommendations │
              │                       │
              │  2. Clinical Report   │
              │     (TXT with:)       │
              │     • Resistance type │
              │     • Morphology      │
              │     • Drug list       │
              │     • Biomarkers      │
              │                       │
              │  3. Machine Data      │
              │     (JSON)            │
              └───────────────────────┘


┌──────────────────────────────────────────────────────────────────────────┐
│                    THERAPY RECOMMENDATION ENGINE                          │
│  (therapy_recommendation_database.py)                                    │
└──────────────────────────────────────────────────────────────────────────┘

Resistance Type → Therapeutic Strategy → Drug Recommendations

Example Flow:

   DRUG EFFLUX RESISTANCE
          │
          ├─ Morphological Features:
          │  • Vesicle-rich cytoplasm
          │  • High membrane signal
          │  • Reduced nucleus-to-cytoplasm ratio
          │
          ├─ Therapeutic Strategy:
          │  "Inhibit drug efflux pumps or use pump-independent drugs"
          │
          ├─ First-Line Drugs:
          │  • P-glycoprotein inhibitors (Valspodar, Tariquidar)
          │  • BCRP inhibitors (Ko143)
          │  • MRP1 inhibitors
          │
          ├─ Second-Line Drugs:
          │  • Liposomal formulations
          │  • Antibody-drug conjugates (ADCs)
          │
          ├─ Combination Therapy:
          │  "Efflux inhibitor + Original chemotherapy"
          │
          ├─ Biomarkers to Test:
          │  • MDR1/P-gp expression
          │  • BCRP
          │  • MRPs
          │
          └─ Monitoring:
             • Intracellular drug accumulation
             • Vesicle formation
             • Membrane transporter expression


┌──────────────────────────────────────────────────────────────────────────┐
│                         KEY INNOVATIONS                                   │
└──────────────────────────────────────────────────────────────────────────┘

1. CHANNEL-AWARE ARCHITECTURE
   ─────────────────────────────
   • Separate encoders for DAPI, Tubulin, Actin
   • Learn channel importance per drug MOA
   • Better feature extraction

2. CONCENTRATION ENCODING
   ────────────────────────
   • Model learns dose-response relationships
   • Low dose vs high dose phenotypes
   • Toxic vs therapeutic concentrations

3. MULTI-TYPE CLASSIFICATION
   ──────────────────────────
   • 7 resistance mechanisms (not binary)
   • Each type has specific morphology
   • Precision therapy mapping

4. THERAPY RECOMMENDATION
   ───────────────────────
   • Resistance type → Drug list
   • Mechanism-based selection
   • Combination therapy suggestions
   • Biomarker testing guidance

5. CHANNEL-WISE GRADCAM
   ───────────────────────
   • Separate explanations per channel
   • "Which cellular compartment matters?"
   • "What features drove the decision?"


┌──────────────────────────────────────────────────────────────────────────┐
│                    COMPARISON: OLD vs NEW                                 │
└──────────────────────────────────────────────────────────────────────────┘

OLD (moa_classifier_train.py):
───────────────────────────────
Input:  Image (RGB stack)
Output: MOA name ("Microtubule stabilizer")
Result: Tells you the drug class, NOT resistance
Use:    Academic exercise, not clinically useful

NEW (LUMIMAP V2):
─────────────────
Input:  DAPI + Tubulin + Actin + Drug + Concentration
Output: Resistance TYPE + Confidence + Therapy + GradCAM
Result: Actionable clinical decision support
Use:    Precision oncology - guides treatment decisions


┌──────────────────────────────────────────────────────────────────────────┐
│                         FILE GUIDE                                        │
└──────────────────────────────────────────────────────────────────────────┘

1. therapy_recommendation_database.py
   ───────────────────────────────────
   • Defines 7 resistance types
   • Maps each type to morphological features
   • Contains drug recommendations for each type
   • Generates clinical reports

2. resistance_type_classifier_train.py
   ────────────────────────────────────
   • Training script
   • Channel-aware CNN architecture
   • Loads BBBC021 data
   • Outputs trained model

3. resistance_inference.py
   ────────────────────────
   • Inference script
   • Loads trained model
   • Generates predictions
   • Creates GradCAM visualizations
   • Produces clinical reports

4. LUMIMAP_README.md
   ─────────────────
   • Complete documentation
   • Usage instructions
   • System architecture
   • Clinical use cases


┌──────────────────────────────────────────────────────────────────────────┐
│                       CLINICAL WORKFLOW                                   │
└──────────────────────────────────────────────────────────────────────────┘

1. Patient on Drug X, showing poor response
   ↓
2. Collect cell sample, perform microscopy
   ↓
3. Stain with DAPI, Tubulin, Actin
   ↓
4. Image cells
   ↓
5. Run LUMIMAP inference:
   python resistance_inference.py \\
     --model best_model.pth \\
     --dapi patient_dapi.tif \\
     --tubulin patient_tubulin.tif \\
     --actin patient_actin.tif \\
     --compound "Drug X" \\
     --concentration 1.0
   ↓
6. LUMIMAP outputs:
   • Resistance type: "Drug Efflux"
   • Confidence: 87%
   • GradCAM: Highlights vesicles
   • Recommendation: "Add P-gp inhibitor"
   ↓
7. Oncologist reviews report
   ↓
8. Order biomarker tests (MDR1/P-gp)
   ↓
9. Adjust therapy:
   • Option A: Add Valspodar (P-gp inhibitor)
   • Option B: Switch to liposomal formulation
   ↓
10. Monitor response


┌──────────────────────────────────────────────────────────────────────────┐
│                      FUTURE ENHANCEMENTS                                  │
└──────────────────────────────────────────────────────────────────────────┘

PHASE 1: Contrastive Learning
──────────────────────────────
Replace pseudo-labels with unsupervised learning:
• Learn MOA phenotypes from multiple compounds
• Use DMSO as baseline
• Generate better resistance labels

PHASE 2: Quantitative Features
───────────────────────────────
Extract explicit morphological measurements:
• Nucleus size, shape, texture
• Mitochondrial distribution
• Cell elongation metrics
• Vesicle counts

PHASE 3: Clinical Validation
─────────────────────────────
• Test on real patient samples
• Correlation with clinical outcomes
• Prospective clinical trial

PHASE 4: Expanded Drug Database
────────────────────────────────
• More compounds
• More MOAs
• Combination therapy modeling


┌──────────────────────────────────────────────────────────────────────────┐
│                           SUMMARY                                         │
└──────────────────────────────────────────────────────────────────────────┘

LUMIMAP V2 transforms cancer drug resistance detection from:

   "Is this cell resistant?"
         ↓
   "Yes/No" → Not actionable

TO:

   "What resistance mechanism is active?"
         ↓
   "Drug Efflux via P-gp" → Add P-gp inhibitor
   "EMT-Like" → Add TGF-β inhibitor
   "Apoptosis Resistance" → Add BCL-2 inhibitor
         ↓
   Precision therapy → Better outcomes


This is the innovation: Moving from binary classification to 
MECHANISM-BASED PRECISION ONCOLOGY.

"""

if __name__ == "__main__":
    print(WORKFLOW_DIAGRAM)
